TUDCA通过激活SIRT1-FXR信号减轻大鼠失血性休克模型中的肝损伤
该研究在大鼠失血性休克模型及缺氧培养的HepG2细胞中,用UPLC-MS/MS检测肝脏胆汁酸谱,发现失血性休克后肝脏TUDCA显著下降,SIRT1和FXR表达随时间下调。TUDCA补充可上调SIRT1-FXR活性,抑制NF-κB和p53的表达与乙酰化,增加FoxM1表达,从而减少炎症反应和肝细胞凋亡、增加增殖能力、减轻肝损伤。SIRT1抑制剂EX527预处理逆转了TUDCA的保护作用,FXR抑制剂Z-guggulsterone在体外也削弱了TUDCA的保护作用。作者认为TUDCA补充可能通过上调SIRT1-FXR信号减轻失血性休克诱导的肝损伤。
要点
- 大鼠失血性休克后肝脏TUDCA显著下降,SIRT1和FXR表达呈时间依赖性下调。
- TUDCA补充上调SIRT1-FXR活性,抑制NF-κB和p53表达及乙酰化、增加FoxM1表达,减少炎症与凋亡、促进肝细胞增殖。
- SIRT1抑制剂EX527预处理可逆转TUDCA的保护作用。
- FXR抑制剂Z-guggulsterone在体外减弱TUDCA的保护作用。
- 作者认为TUDCA补充可能通过上调SIRT1-FXR信号减轻失血性休克诱导的肝损伤。
适用人群与场景
- SD大鼠失血性休克模型;体外为缺氧培养的HepG2细胞模拟失血性休克。
研究设计与关键结果
- 研究类型:动物实验(SD大鼠失血性休克模型)联合体外细胞实验(缺氧培养HepG2细胞)。
- 失血性休克后肝脏TUDCA显著下降;SIRT1和FXR表达在失血性休克或缺氧条件下呈时间依赖性下调。
- TUDCA上调SIRT1-FXR活性,抑制NF-κB和p53的表达与乙酰化、增加FoxM1表达,导致炎症反应和凋亡减少、肝细胞增殖能力增加、肝损伤减轻。
- SIRT1抑制剂EX527预处理逆转了TUDCA的保护作用。
- FXR抑制剂Z-guggulsterone在体外减弱了TUDCA的保护作用。
证据类型、等级与局限
- 证据类型:动物实验与体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为TUDCA补充可能通过上调SIRT1-FXR信号减轻失血性休克诱导的肝损伤。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was to investigate the changes of bile acids in the liver during hemorrhagic shock (HS) and their potential to attenuate liver injury via activation of SIRT1 (sirtuin 1)-FXR (farnesoid X receptor) signaling.
METHODS: A Sprague-Dawley (SD) rat HS model was established, whereas HepG2 cells were hypoxically cultured to simulate HS in vitro. Liver bile acids (BA) were profiled with ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). FXR expression was detected by western blot and immunohistochemistry. The mRNA levels of SIRT1 and FXR were detected by polymerase chain reaction. Protein expression of SIRT1, FoxM1, NF-κB, acetyl-NF-κB, p53, and acetyl-p53 was analyzed by western blot. Hepatocyte apoptosis and proliferation were measured by TUNEL assay and Ki-67 staining, respectively. Serum and supernatant cytokines were analyzed using ELISA assays. Liver injury was also assessed. To investigate the possible mechanisms, SIRT1 agonist (SRT1720), SIRT1 inhibitor (EX527), and FXR inhibitor (Z-guggulsterone) were used.
RESULTS: Tauroursodeoxycholic acid (TUDCA) in the liver decreased significantly after HS. SIRT1 and FXR expression was time-dependently downregulated by HS or hypoxia condition. TUDCA upregulated SIRT1-FXR activity, which inhibited expression and acetylation of NF-κB and p53 and increased FoxM1 expression, leading to decreased inflammatory response and apoptosis and increased proliferative capacity in hepatocytes, and attenuation of liver injury. EX527 pretreatment reversed the protective effect of TUDCA. Moreover, Z-guggulsterone supplementation decreased the protective effect of TUDCA in vitro.
CONCLUSION: TUDCA in the liver decreased during HS. TUDCA supplementation might attenuate HS-induced liver injury by upregulating SIRT1-FXR signaling.
参考来源
- Sun S, Zhao B, Qi M, et al. TUDCA Ameliorates Liver Injury Via Activation of SIRT1-FXR Signaling in a Rat Hemorrhagic Shock Model. Shock. 2020. PMID: 30998645. doi:10.1097/SHK.0000000000001351
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。